The research states that SSRIs, or selective serotonin reuptake inhibitors, are often prescribed drugs for the treatment of seasonal affective disorder. In the market for seasonal affective disorder treatments industry, there are numerous branded and generic drugs accessible, however Buproban and Citalopram continue.
/PRNewswire/ The light therapy market is expected to grow by USD 246.87 million from 2022 to 2027. In addition, the momentum of the market will progress at.
The global Seasonal Affective Disorder (SAD) Therapeutics market demnad is poised for substantial growth, with a projected valuation close to US$ 1.1 Billion by the end of 2028. Seasonal Affective Disorder, commonly known as winter depression, is a mood disorder that affects individuals during specific seasons, typi.
fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.